4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-109450
Chief Accounting Officer sold 2,352 shares at $5.98 ($14,065)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Definium Therapeutics, Inc. Filed Acc 0000950170-24-109450
Chief Accounting Officer sold 2,352 shares at $5.98 ($14,065)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…